China NT Pharma Group Co., Ltd. (1011) Stock Statistics & Valuation Metrics

China NT Pharma Group Co., Ltd. has a market cap or net worth of HKD 440.16M. The enterprise value is HKD 787.72M.

Market Cap

HKD 440.16M

Enterprise Value

HKD 787.72M

China NT Pharma Group Co., Ltd. has 1,796,563,600 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

1,796,563,600

Owned by Insiders

―

Owned by Institutions

―

China NT Pharma Group Co., Ltd.’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -28.83%.

Return on Equity (ROE)

0.10

Return on Assets (ROA)

-0.07

Return on Invested Capital (ROIC)

-28.83%

Return on Capital Employed (ROCE)

0.05

Revenue Per Employee

754.94K

Profits Per Employee

-813.78K

Employee Count

32

Asset Turnover

0.07

Inventory Turnover

36.26

The current PE Ratio of China NT Pharma Group Co., Ltd. is -5.83. China NT Pharma Group Co., Ltd.’s PEG ratio is -0.05.

PE Ratio

-5.83

PS Ratio

3.84

PB Ratio

-1.53

Price to FCF

-6.87

Price to Operating Cash Flow

-8.67

PEG Ratio

-0.05

In the last 12 months, China NT Pharma Group Co., Ltd. had revenue of 24.16M and earned -26.04M in profits. Earnings per share was -0.04.

Revenue

24.16M

Gross Profit

9.61M

Operating Income

-12.36M

Pretax Income

-26.25M

Net Income

-26.04M

EBITDA

-11.72M

Earnings Per Share (EPS)

-0.04

In the last 12 months, operating cash flow was -19.66M and capital expenditures -154,883, giving a free cash flow of -19.82M billion.

Operating Cash Flow

-19.66M

Free Cash Flow

-19.82M

Free Cash Flow per Share

-0.02

China NT Pharma Group Co., Ltd. pays an annual dividend of HKD 0.04, resulting in a dividend yield of ―

Dividend Per Share

HKD 0.04

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-14.55%

Earnings Yield

-16.03%

Beta

1.04

52-Week Price Change

-68.99%

50-Day Moving Average

0.37

200-Day Moving Average

0.53

Relative Strength Index (RSI)

25.78

Average Volume (3m)

308.47K

China NT Pharma Group Co., Ltd. upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 20, 2026

Next Earnings Date

Apr 01, 2027

Ex-Dividend Date

Jul 10, 2018

China NT Pharma Group Co., Ltd. as a current ratio of 0.02, with Debt / Equity ratio of -115.74%

Current Ratio

0.02

Quick Ratio

0.02

Debt to Market Cap

0.70

Net Debt to EBITDA

-26.42

Interest Coverage Ratio

-0.46

In the past 12 months, China NT Pharma Group Co., Ltd. has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

China NT Pharma Group Co., Ltd. EV to EBITDA ratio is -35.59, with an EV/FCF ratio of -23.17.

EV to Sales

12.94

EV to EBITDA

-35.59

EV to Free Cash Flow

-23.17

EV to Operating Cash Flow

-23.35

China NT Pharma Group Co., Ltd. has HKD 11.91M in cash and marketable securities with HKD 334.93M in debt, giving a net cash position of -HKD 323.02M billion.

Cash & Marketable Securities

HKD 11.91M

Total Debt

HKD 334.93M

Net Cash

-HKD 323.02M

Net Cash Per Share

-HKD 0.18

Tangible Book Value Per Share

-HKD 0.40

Gross margin is 16.46%, with operating margin of -39.00%, and net profit margin of -76.94%.

Gross Margin

16.46%

Operating Margin

-39.00%

Pretax Margin

-72.27%

Net Profit Margin

-76.94%

EBITDA Margin

-36.34%

EBIT Margin

-39.00%

The average price target for China NT Pharma Group Co., Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

100.34%

EPS Growth Forecast

83.97%

Smart Score

1

AI Score

42